Multidrug-Resistant Tuberculosis Complicated by Nosocomial Infection with Multidrug-Resistant Enterobacteriaceae

Am J Trop Med Hyg. 2016 Mar;94(3):517-8. doi: 10.4269/ajtmh.15-0690. Epub 2016 Jan 11.

Abstract

Treatment of mycobacterial diseases such as tuberculosis (TB) entails long and intense antimicrobial therapy. TB patients are at risk of coinfection with other multidrug-resistant bacteria, such as those from Enterobacteriaceae family, because of antimicrobial selection pressure and nosocomial transmission during prolonged hospital admission. Here, we report on two patients treated for multidrug-resistant TB, who developed severe sepsis due to an extended spectrum β-lactamase producing organism. Diagnostic culture identified the venous access port as source, and upon surgical removal and antimicrobial therapy rapid clinical improvement was achieved. Increased awareness and knowledge on the prevalence of multi-resistant Enterobacteriaceae is needed, notably in TB centers, to provide a safe hospital environment to our patients.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Bacterial Agents / pharmacology
  • Antitubercular Agents / administration & dosage
  • Antitubercular Agents / therapeutic use*
  • Cross Infection
  • Enterobacteriaceae
  • Enterobacteriaceae Infections / etiology*
  • Enterobacteriaceae Infections / microbiology*
  • Enterobacteriaceae Infections / pathology
  • Female
  • Humans
  • Tuberculosis, Multidrug-Resistant / complications*

Substances

  • Anti-Bacterial Agents
  • Antitubercular Agents